Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Issue Date
1999-03-01
Metadata
Show full item recordCitation
Allergy 1999, 54 Suppl 49:55-61Abstract
Reversible or partially reversible airway obstruction, inflammation, and bronchial hyperresponsiveness to various stimuli are the defining characteristics of asthma. Airway obstruction in asthma is a complex event that is due to bronchospasm, inflammation, and mucus formation. Inflammation has assumed a more central role in the pathogenesis of the disease, as it contributes not only to airflow obstruction, but also to bronchial hyperresponsiveness. The inciting trigger, or inhaled allergen, in asthma induces the activation of mast cells and macrophages with the subsequent release of several proinflammatory mediators, including leukotrienes, chemotactic factors, and cytokines. Antigen processed by macrophages is presented to undifferentiated T helper cells, inducing differentiation to the Th2 phenotype, with the subsequent release of IL-4 and IL-5, causing IgE synthesis and eosinophil infiltration, respectively. Macrophage-derived cytokines, such as IL-1, TNF-alpha, and IFN-gamma, activate endothelial cells, upregulating the expression of adhesion molecules such as ICAM-1 and VCAM-1, which permit egression of leukocytes from the vasculature to the airway mucosa. Several inflammatory cells, such as eosinophils, mast cells, and macrophages, not only cause airway damage, but also synthesize cytokines that perpetuate the inflammatory process. This complex interplay of inflammatory cells and mediators causes the classic histopathophysiologic features in the airways of both symptomatic and asymptomatic individuals with asthma, emphasizing the importance of early recognition and antiinflammatory treatment.Description
To access publisher full text version of this article. Please click on the hyperlink in Additional Links fieldAdditional Links
http://dx.doi.org/10.1111/j.1398-9995.1999.tb04389.xae974a485f413a2113503eed53cd6c53
10.1111/j.1398-9995.1999.tb04389.x
Scopus Count
Collections
Related articles
- Understanding asthma pathophysiology.
- Authors: Fireman P
- Issue date: 2003 Mar-Apr
- An update on the immunopathogenesis of asthma as an inflammatory disease enhanced by environmental pollutants.
- Authors: Casillas AM, Nel AE
- Issue date: 1997 Jul-Aug
- The pathobiology of bronchial asthma.
- Authors: Arm JP, Lee TH
- Issue date: 1992
- The airway inflammatory response in allergic asthma and its relationship to clinical disease.
- Authors: Howarth PH
- Issue date: 1995
- Proinflammatory and Th2-derived cytokines modulate CD40-mediated expression of inflammatory mediators in airway epithelia: implications for the role of epithelial CD40 in airway inflammation.
- Authors: Propst SM, Denson R, Rothstein E, Estell K, Schwiebert LM
- Issue date: 2000 Aug 15